Author: Civica Rx

Vizient, based in Irving Texas, will provide insights into purchasing patterns and provider needs through their analytics and data capabilities, helping Civica anticipate gaps in drug availability and affordability. “We applaud Vizient for helping to find innovative ways to reduce drug shortages through their analytics and data expertise,” said Martin VanTrieste, Civica CEO.  “The...

Civica Rx announces its first supplier partner, Xellia Pharmaceuticals. Xellia will manufacture essential antibiotics, including Vancomycin and Daptomycin, for Civica’s member health systems to address shortages of these anti-infective medications and improve patient care in hospitals across the US. Today marks the first time that Civica is announcing the production of generic drugs –...

Commentary from Civica Rx CEO Martin VanTrieste: We are halfway through Civica Rx’s first year. When I reflect on all that has happened since our company’s launch in September 2018, I am proud of what we have accomplished and more motivated than ever to deliver on our mission of making essential generic medications accessible...

Salt Lake City, UT, February 16, 2019 – Civica Rx is proud to announce that Heather Wall, Chief Commercial Officer, has been recognized by Modern Healthcare as one of 2019’s Women Leaders to Watch in Healthcare. The profiles of all the winners are featured in the February 18, 2019 print issue of Modern Healthcare...

FierceHealthcare names CivicaRx as one of it's 2019 “Fierce 15” Companies Civica Rx is honored to have been named by FierceHealthcare as one of the 2019 Fierce 15 companies, designating it as one of the most promising healthcare companies in the industry. The Fierce 15 celebrates the spirit of being “fierce” – championing innovation...

Momentum reflects commitment of nearly 750 hospitals to date Salt Lake City, UT, January 7, 2019 – Civica Rx has announced that 12 health systems, representing approximately 250 hospitals across the United States, have joined the new not-for-profit generic drug company as founding members. When combined with hospitals represented by the initial governing members...

Civica’s MISSION Ensure that essential generic drugs are available and affordable to everyone Civica’s VISION To be a model generic drug company by providing high-quality FDA approved products at affordable prices Civica’s VALUES Safety, Quality, Accessibility, Affordability and Fairness What's Next? Civica expects to bring over 14 hospital-administered generic drugs to hospitals and health...

New not-for-profit company Civica Rx is established by seven hospital systems and 3 charitable foundations (as reported in FORBES) to address a persistent drug shortage problem that has become a national crisis for hospitals and patients. New leadership Civica Rx announces that Dan Liljenquist, SVP and chief strategy officer at Intermountain Healthcare, will serve as chair of the Civica...

Civica Rx was established in 2018 to address a persistent drug shortage problem that has become a national crisis for hospitals and patients. Civica, a mission-driven, not-for-profit, non-stock generic drug company, was founded by leading hospital systems that know first-hand about the impact of the inconsistent, unpredictable, and often unstable market dynamics that lead...

Civica Rx CEO Martin VanTrieste participated in the November 27th, 2018 FDA Workshop on Drug Shortages at Duke University.  ...